e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study
Lorenzo Guglielmetti, Simon Tiberi, Matthew Burman, Heinke Kunst, Christian Wejse, Tamar Togonidze, Graham Bothamley, Christoph Lange
Source:
Eur Respir J, 52 (2) 1800537; 10.1183/13993003.00537-2018
Journal Issue:
August
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lorenzo Guglielmetti, Simon Tiberi, Matthew Burman, Heinke Kunst, Christian Wejse, Tamar Togonidze, Graham Bothamley, Christoph Lange. QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study. Eur Respir J, 52 (2) 1800537; 10.1183/13993003.00537-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?
Source: Eur Respir J 2012; 39: 619-625
Year: 2012
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation
Source: Eur Respir J, 53 (1) 1802089; 10.1183/13993003.02089-2018
Year: 2019
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis
Source: Eur Respir J 2002; 19: 765-775
Year: 2002
Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey
Source: Eur Respir J 2008; 32: 1023-1030
Year: 2008
The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis
Source: Breathe, 13 (3) e65; 10.1183/20734735.005517
Year: 2017
Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes
Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018
Year: 2018
Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study
Source: Eur Respir J, 56 (1) 1902004; 10.1183/13993003.02004-2019
Year: 2020
Tuberculosis treatment outcome monitoring in European Union countries: systematic review
Source: Eur Respir J 2013; 41: 635-643
Year: 2013
Comparison of tuberculosis surveillance systems in low-incidence industrialised countries
Source: Eur Respir J 2008; 32: 1616-1624
Year: 2008
Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease
Source: Eur Respir J 2016; 47:1345-1347
Year: 2016
Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe},
Source: Eur Respir J 2012; 40: 806-808
Year: 2012
Respiratory health and disease in Europe: the new European Lung White Book
Source: Eur Respir J 2013; 42: 559-563
Year: 2013
National evidence on the inefficiency of an inpatient model of tuberculosis management in Eastern Europe
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Tuberculosis and HIV co-infection in European Union and European Economic Area countries
Source: Eur Respir J 2011; 38: 1382-1392
Year: 2011
Evaluation of the accuracy of tuberculosis surveillance system by comparison with medical record in Korea
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Sustainability of Russian GLC approved projects and treatment success rate in Russian MDR-TB cohort 2010
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey
Source: International Congress 2019 – Tuberculosis: treatment and management
Year: 2019
Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation
Source: Eur Respir J 2014; 43: 554-565
Year: 2013
Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept